Filing Details

Accession Number:
0001213900-21-039435
Form Type:
4
Zero Holdings:
No
Publication Time:
2021-07-30 09:50:08
Reporting Period:
2021-07-28
Accepted Time:
2021-07-30 09:50:08
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1739174 Biomx Inc. PHGE Biological Products, (No Disgnostic Substances) (2836) 000000000
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1789914 Russell Greig C/O Biomx Ltd.,
22 Einstein St., 5Th Floor
Ness Ziona, L3 7414003
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2021-07-28 3,750 $4.00 3,750 No 4 P Indirect See Footnote
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Indirect See Footnote
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Common Stock Warrant Acquisiton 2021-07-28 2,813 $0.00 2,813 $5.00
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
2,813 2022-01-28 2027-01-28 No 4 P Indirect
Footnotes
  1. The common stock and common stock warrant were acquired in the issuer's registered direct offering of units, in which each unit consisted of one share of common stock and one common stock warrant to purchase 0.75 of a share of common stock, at a price of $4.00 per unit. The price paid per unit is reflected in Table I.
  2. The common stock warrant will be exercisable six months after the date of issuance, at an exercise price of $5.00 per share and will expire five years from the date such warrant first becomes exercisable.
  3. The common stock and common stock warrant are held by Greig Biotechnology Global Consulting Inc.; Mr. Greig, as the sole director, an officer and the controlling shareholder of Greig Biotechnology Global Consulting Inc., may be deemed to be a beneficial owner of these shares, but Mr. Greig disclaims such beneficial ownership except to the extent of his pecuniary interest therein.